Certified in December 2017 by INCa (National Institute of Cancer), ILIAD is one of the eight SIRICs founded on the model of integration of Comprehensive Care Centre research.
ILIAD brings together medical, scientific and technological expertise while combining different disciplines (nuclear medicine, oncology, hematology, biological sciences, human and social sciences, epidemiology, chemistry, physics and mathematics) within a consortium of 9 research laboratories, 3 health establishments and 27 high level technological platforms.
ILIAD is underpinned by integrated research, which is innovative and multidisciplinary, structured around heterogeneity and tumour resistance. Articulated around the care pathway, the research carried out by the ILIAD teams also relates to the life of the patients by integrating the issues of social inequality and how to retain a job when faced with illness.
The research programmes are represented by two tumours which have been chosen as demonstrators: multiple myeloma and breast cancer.
Presentation

Program 1

NUCLEAR ONCOLOGY

Developing nuclear medicine tools in order to predict the prognosis and elaborate innovative targeted and personalised therapies.

Programme 2

FUNCTIONAL CELLULAR ONCOLOGY

Developing functional personalised medicine tools combining predictive algorithms and cellular tests.

Programme 3

HUMAN AND SOCIAL SCIENCES

Developing tools to identify and correct social inequality and the return to work.

News

logo CHU Nantes
Logo ICO
logo_chu_angers451x307
Logo INSERM
Logo_arronax
universite-de-nantes-logo
Université d'Angers logo
ecole-centrale-nantes-logo
EPIC PL Logo
logo-atlanpole

Start typing and press Enter to search